| No. | 045 |
| Project Title | Development of a 3D flow through model for long-term culture of polarized hepatocytes (-like cells) in vitro |
| Project Leader | Dr. Sabrina Ehnert & Prof. Dr. Andreas K. Nüssler |
| Organisation | University of Tübingen (Germany) |
| Duration | 04/2011 - 03/2013 |
| No. | 044 |
| Project Title | Development of an in vitro method for the determination of tetanus toxicity in tetanus vaccines |
| Project Leader | Dr. Karin Weisser, Dr. Beate Krämer |
| Organisation | Paul-Ehrlich-Institut, Langen (Germany) |
| Duration | 02/2011 - 04/2012 |
| No. | 043 |
| Project Title | Development of an in vitro test system for cancerogenicity testing of chemicals with high throughput |
| Project Leader | Prof. Dr. Pablo Steinberg |
| Organisation | TiHo Hannover |
| Duration | 12/2010 - 11/2011 |
| No. | 042 |
| Project Title | Development of a Reverse Transcriptase Real Time-PCR assay for the detection of Clostridium botulinum Typ A, B, E and F neurotoxin-production in foods as an alternative method to the mouse bioassay |
| Project Leader | Prof. Dr. Michael Bülte |
| Organisation | Universität Giessen |
| Duration | 12/2007 - 11/2010 |
| No. | 041 |
| Project Title | Development of an in vitro model of rheumatoid joint destruction by using cross-linked fluorescent-labeled collagen matrices |
| Project Leader | Prof. Dr. Thomas Pap |
| Organisation | Universität Münster |
| Duration | 10/2007 - 09/2009 |
| No. | 040 |
| Project Title | Improved genotoxicity tests with the Phenion® Full Thickness Skin Model |
| Project Leader | Dr. Kerstin Reisinger |
| Organisation | Phenion GmbH & Co. KG, Düsseldorf |
| Duration | 09/2007 - 08/2009 |
| No. | 039 |
| Project Title | Pharmacological Screening using human embryonic stem cell derived cardiomyocytes |
| Project Leader | Dr. Michael Reppel, Prof. Dr. Hescheler |
| Organisation | Universität Köln |
| Duration | 06/2006 - 05/2008 |
| No. | 037 |
| Project Title | Establishment of in vitro models for neuroprotection with molecular connotations to human neurodegenerative diseases |
| Project Leader | Prof. Dr. André Schrattenholz |
| Organisation | ProteoSys AG, Mainz, Germany |
| Duration | 03/2006 - 02/2007 |
| No. | 036 |
| Project Title | Screening and evaluation of antiepileptic compounds in vitro: organotypic cultures of hippocampus as a model of ictaform activity and epileptogenesis |
| Project Leader | Prof. Dr. med. U. Heinemann / Prof. Dr. med. Klaus Albus |
| Organisation | Charité, Berlin |
| Duration | 06/2005 - 05/2007 |
English